Pfizer Beats Q4 Revenue, EPS Estimates

Pfizer reported robust fourth-quarter 2024 earnings, exceeding expectations in both revenue and adjusted earnings.Pharmaceuticals giant Pfizer (PFE 0.25%) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. The company reported an adjusted earnings per share of $0.63, significantly above the analyst consensus of$0.47, while generating revenue of $17.76 billion, surpassing expectations of$17.35 billion. Despite a significant year-over-year decl ...